Sarilumab for Patients With Moderate COVID-19 Disease
NCT04359901
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
FED
Sponsor class
Conditions
COVID
Interventions
BIOLOGICAL:
SARILUMAB
Sponsor
Westyn Branch-Elliman